Cytokine Signalling Forum

CME Courses




« Return to Overview

ACR 2021 Congress Review Webinar

ACR 2021 Congress Review Webinar
Developed by CESAS Medical, under the auspices of the University of Glasgow This activity is supported by unrestricted educational grants from Lilly

01 December 2021
Estimated time to complete activity: 1 hour 36 minutes
Compatible with all modern internet browsers and mobile devices

EDUCATIONAL OBJECTIVES
After completing this activity, the learner will:
  • Understand the modes of action of JAK inhibitors in RAli>
  • Understand the latest clinical safety and efficacy data of JAK inhibitors from ACR 2021
  • Discuss other key highlights from ACR 2021

TARGET AUDIENCE
This activity is designed for qualified rheumatologists of all levels of seniority, and other healthcare professionals involved in treating patients with inflammatory disease.

PROGRAMME OVERVIEW
ACR 2021 presented new scientific and clinical information on cytokine signalling science that will shape the rheumatology treatment landscape. Data presented included new data on the role of JAK inhibitors in the treatment paradigm for rheumatoid arthritis.

In this activity, ACR 2021 Congress Review Webinar, international experts review and discuss key abstracts and data from ACR 2021 JAK inhibitors and the management of rheumatoid arthritis in clinical practice

INSTRUCTIONS FOR PARTICIPATION
Participants must 1) read the activity information; 2) study the educational activity; 3) successfully complete the post-module assessments with a score of 80% or better; 4) and complete the evaluation form. Upon completion of the full activity, your certificate will be made available to download and print.

DISCLOSURE OF CONFLICTS OF INTEREST
CESAS Medical requires faculty, presenters, planners, managers, writers, and any other individuals who are in a position to influence the content of this activity to disclose any real and/or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly reviewed and resolved according to CESAS Medical policy.

Module Presenter Video Questions
ACR 2021 Congress Review Webinar
Professor Johannes W.J. Bijlsma image
Professor Johannes W.J. Bijlsma

Professor and Head of the Department of Rheumatology and Clinical Immunology,
University Medical Centre, Utrecht, The Netherlands

Professor Bijlsma is the past President of EULAR (2017-2019), and a Professor of Rheumatology at the University Medical Centre, Utrecht, The Netherlands.

He acquired his Medical degree and PhD from the University of Utrecht and has been a Professor of Rheumatology since 1990. Professor Bijlsma was the Chairman of The EULAR Standing Committee on Education and Training, EULAR Educational Officer and has been EULAR Treasurer. He has also held a variety of roles from 1992-2008 at the Dutch Society for Rheumatology, including Scientific Secretary, President and Chairman Consilium. He is chairman of the Advisory Board of the Annals of Rheumatic Diseases and is on the editorial board of Clinical and Experimental Rheumatology, Best Practice & Research Clinical Rheumatology and Clinical Rheumatology.

Professor Bijlsma researches and specialises in immune aspects of rheumatic diseases and Osteoarthritis. He has authored and co-authored over 800 articles published in peer-reviewed international journals, has contributed chapters in a number of textbooks, and has edited and co-edited several books in the field of Rheumatology, including the EULAR Textbooks.

Prof. Johannes W.J. Bijlsma (Bio)
Professor Peter Taylor image
Professor Peter Taylor

Norman Collisson Professor of Musculoskeletal Sciences,
University of Oxford, Oxford, UK

Professor Peter Taylor studied pre-clinical medical sciences at Gonville and Caius College at the University of Cambridge, where he earned his first degree in Physiology. He subsequently studied clinical medicine at the University of Oxford and was awarded a PhD degree from the University of London for studies on the pathogenesis of arthritis. In October 2011, Professor Taylor was appointed Norman Collisson Chair of Musculoskeletal Sciences at the University of Oxford, and is a Fellow of St. Peter's College, Oxford. He is the Head of Clinical Sciences at the Botnar Research Centre within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences.

He has specialist clinical interests in novel therapies, rheumatoid and early arthritis. His research expertise is in mechanisms sustaining inflammation and clinical trials of new therapies with development of novel outcome measurements for application in assessment of response to therapy.

Prof. Peter Taylor (Bio)
Professor Janet Pope image
Professor Janet Pope

Professor of Medicine in the Division of Rheumatology,
University of Western Ontario Schulich School of Medicine

Professor Pope is a Professor of Medicine in the Division of Rheumatology at the University of Western Ontario, Schulich School of Medicine, and Division Head in Rheumatology at St Joseph's Health Care in London, Ontario, Canada.

She obtained her Masters degree in Public Health and Fellowship in Rheumatology from Boston University. She then completed a Canadian Arthritis Society Research Fellow in Scleroderma. She is a section editor of Arthritis & Rheumatology, and on the Editorial Boards of Journal of Rheumatology, Nature Reviews Rheumatology, Lancet Rheumatology, RMD Open.

Her research includes epidemiologic studies in scleroderma, systemic lupus erythematosus (SLE) and RA, including outcome measurements, clinical trials and disease manifestations. She has published over 500 peer-reviewed articles, 15 chapters, 600 abstracts, and several Cochrane meta-analysis reviews.

Prof. Janet Pope (Bio)
96:15 0

Date of preparation: 01 December 2021